MorphoSys to Present Data on Proprietary Programs at 20th Congress of EHA

News   May 26, 2015

 
MorphoSys to Present Data on Proprietary Programs at 20th Congress of EHA
 
 
 

RELATED ARTICLES

Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing Sites

News

Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.

READ MORE

CBD Significantly Reduces Seizures in Patients with Severe Form of Epilepsy

News

Large-scale clinical trial finds cannabidiol can dramatically reduce the number of dangerous seizures in patients with a severe form of epilepsy called Lennox–Gastaut syndrome.

READ MORE

New Approach to Cancer Research Aims to Accelerate Studies and Reduce Cost

News

A new model for improving how clinical trials are developed and conducted by bringing together academic cancer experts and pharmaceutical companies is being tested by research experts at The University of Texas MD Anderson Cancer Center.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE